• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

识别先天性干预技术的差距:对先天性介入心脏病专家需求调查的分析

Identifying Gaps in Technology for Congenital Interventions: Analysis of a Needs Survey from Congenital Interventional Cardiologists.

作者信息

Shibbani Kamel, Kenny Damien, McElhinney Doff, Hijazi Ziyad M, Moran Tim

机构信息

Lieber Institute For Brain Development, Johns Hopkins, Baltimore, MD, USA.

Our Lady's Hospital for Sick Children, Crumlin, Dublin 12, Ireland.

出版信息

Pediatr Cardiol. 2016 Jun;37(5):925-31. doi: 10.1007/s00246-016-1372-0. Epub 2016 Apr 11.

DOI:10.1007/s00246-016-1372-0
PMID:27064094
Abstract

We carried out a device-needs survey to evaluate the gaps in device and equipment availability for congenital interventional cardiologists. As the complexity and demand for more complete solutions to congenital heart lesions increase, there is a growing need for modification and development of devices and equipment to support this endeavor. The survey was sent out via e-mail to members of the Congenital Cardiovascular Interventional Study Consortium and the Society for Cardiac Angiography and Interventions with a reach of over 350 congenital interventionalists. Responses were received from 68 cardiologists in 8 countries. In terms of the most desired device, 41 % ranked bioresorbable stents as their first choice from a list of 12 possible devices. Similarly, 23 % ranked large covered stents as their first choice. Twenty-seven percent of participants believed bioresorbable stents would have the greatest potential to improve morbidity of their patients, with another 27 % reporting that covered stents would have the greatest impact. Fifty percent of participants reported that they would like to see large covered stents available in their country. These data point toward a perceived need for the development/approval of bioresorbable stents for the pediatric age group, as well as the need to approve the use of large covered stents in the pediatric age group in the USA.

摘要

我们开展了一项设备需求调查,以评估先天性介入心脏病专家在设备和器械可用性方面的差距。随着先天性心脏病病变更完整解决方案的复杂性和需求不断增加,对支持这项工作的设备和器械进行改进和开发的需求也日益增长。该调查通过电子邮件发送给先天性心血管介入研究联盟和心血管造影与介入学会的成员,覆盖了350多名先天性介入专家。共收到来自8个国家68位心脏病专家的回复。在最期望的设备方面,在12种可能的设备中,41%将生物可吸收支架列为首选。同样,23%将大的覆膜支架列为首选。27%的参与者认为生物可吸收支架对改善患者发病率具有最大潜力,另有27%报告称覆膜支架影响最大。50%的参与者表示希望在本国能有大的覆膜支架。这些数据表明,人们认为需要为儿童年龄组开发/批准生物可吸收支架,以及在美国批准在儿童年龄组使用大的覆膜支架。

相似文献

1
Identifying Gaps in Technology for Congenital Interventions: Analysis of a Needs Survey from Congenital Interventional Cardiologists.识别先天性干预技术的差距:对先天性介入心脏病专家需求调查的分析
Pediatr Cardiol. 2016 Jun;37(5):925-31. doi: 10.1007/s00246-016-1372-0. Epub 2016 Apr 11.
2
Transcatheter interventions in adults with congenital heart disease: Surveys from the Society for Cardiovascular Angiography and Interventions to identify current patterns of care and perception on training requirements.成人先天性心脏病的经导管介入治疗:心血管造影和介入学会的调查,以确定当前的护理模式和对培训要求的看法。
Catheter Cardiovasc Interv. 2017 Sep 1;90(3):418-424. doi: 10.1002/ccd.27151. Epub 2017 Jun 1.
3
Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: a survey of 374 interventional cardiologists.冠状动脉支架围手术期管理及术前冠状动脉血运重建的当代方法:对374名介入心脏病学家的调查
Cardiovasc Revasc Med. 2011 Mar-Apr;12(2):99-104. doi: 10.1016/j.carrev.2009.09.007. Epub 2010 Oct 20.
4
Contemporary approaches to saphenous vein graft interventions: a survey of 275 interventional cardiologists.当代隐静脉移植介入治疗方法:275 名介入心脏病学家的调查。
Catheter Cardiovasc Interv. 2012 Apr 1;79(5):834-42. doi: 10.1002/ccd.23111. Epub 2011 May 11.
5
Composite self-expanding bioresorbable prototype stents with reinforced compression performance for congenital heart disease application: Computational and experimental investigation.用于先天性心脏病应用的具有增强压缩性能的复合自膨式可吸收原型支架:计算和实验研究。
J Mech Behav Biomed Mater. 2018 Aug;84:126-134. doi: 10.1016/j.jmbbm.2018.05.009. Epub 2018 May 8.
6
Stents in paediatric and adult congenital interventional cardiac catheterization.儿科及成人先天性介入心脏导管插入术中的支架
Arch Cardiovasc Dis. 2014 Aug-Sep;107(8-9):462-75. doi: 10.1016/j.acvd.2014.06.005. Epub 2014 Aug 12.
7
Interventional treatment of congenital heart disease patients.先天性心脏病患者的介入治疗。
Minerva Cardioangiol. 2010 Feb;58(1):79-96.
8
Core curriculum for the training of pediatric invasive/interventional cardiologists: report of the Society for Cardiac Angiography and Interventions Committee on Pediatric Cardiology Training Standards.儿科侵入性/介入心脏病学家培训核心课程:心脏血管造影和介入学会儿科心脏病学培训标准委员会报告
Cathet Cardiovasc Diagn. 1996 Apr;37(4):409-24. doi: 10.1002/(SICI)1097-0304(199604)37:4<409::AID-CCD10>3.0.CO;2-A.
9
Pediatric interventional cardiology: the cardiologist's role and relationship with pediatric cardiothoracic surgery.小儿介入心脏病学:心脏病专家的角色及其与小儿心胸外科的关系。
Adv Card Surg. 2001;13:143-67.
10
[Interventional cardiology in Lithuania: current status and perspectives].
Medicina (Kaunas). 2004;40 Suppl 1:100-2.

引用本文的文献

1
Initial status and 3-month results relating to the use of biodegradable nitride iron stents in children and the evaluation of right ventricular function.儿童使用可生物降解氮化铁支架的初始状态及3个月结果与右心室功能评估
Front Cardiovasc Med. 2022 Aug 1;9:914370. doi: 10.3389/fcvm.2022.914370. eCollection 2022.
2
Bioresorbable Stent to Manage Congenital Heart Defects in Children.用于治疗儿童先天性心脏病的生物可吸收支架
Materialia (Oxf). 2021 May;16. doi: 10.1016/j.mtla.2021.101078. Epub 2021 Mar 19.
3
Preclinical comparative assessment of a dedicated pediatric poly-L-lactic-acid-based bioresorbable scaffold with a low-profile bare metal stent.

本文引用的文献

1
Morphologic characterization of the patent ductus arteriosus in the premature infant and the choice of transcatheter occlusion device.早产儿动脉导管未闭的形态学特征及经导管封堵装置的选择
Catheter Cardiovasc Interv. 2016 Feb 1;87(2):310-7. doi: 10.1002/ccd.26287. Epub 2015 Nov 3.
2
Bioresorbable scaffolds for percutaneous coronary interventions.用于经皮冠状动脉介入治疗的生物可吸收支架
Glob Cardiol Sci Pract. 2014 Dec 31;2014(4):409-27. doi: 10.5339/gcsp.2014.55. eCollection 2014.
3
First reported use of drug-eluting bioabsorbable vascular scaffold in congenital heart disease.
专用儿科聚左旋乳酸基生物可吸收支架与低轮廓裸金属支架的临床前比较评估。
Catheter Cardiovasc Interv. 2020 Oct 1;96(4):878-888. doi: 10.1002/ccd.28893. Epub 2020 Apr 15.
4
Interventional Cardiology for Congenital Heart Disease.先天性心脏病的介入心脏病学
Korean Circ J. 2018 May;48(5):350-364. doi: 10.4070/kcj.2018.0064. Epub 2018 Mar 29.
药物洗脱生物可吸收血管支架在先天性心脏病中的首次报道应用。
Catheter Cardiovasc Interv. 2016 Feb 1;87(2):324-8. doi: 10.1002/ccd.25768. Epub 2015 Nov 28.
4
A novel technique for transcatheter patent ductus arteriosus closure in extremely preterm infants using commercially available technology.一种使用市售技术对极早产儿进行经导管动脉导管未闭封堵的新技术。
Catheter Cardiovasc Interv. 2015 Feb 1;85(2):240-8. doi: 10.1002/ccd.25534. Epub 2014 May 20.
5
Covered stents for coarctation of the aorta: treating the interventionalist or the patient?
JACC Cardiovasc Interv. 2014 Apr;7(4):424-5. doi: 10.1016/j.jcin.2013.12.200. Epub 2014 Mar 13.
6
Transcatheter occlusion of the patent ductus arteriosus in infants: experimental testing of a new Amplatzer device.经导管动脉导管未闭封堵术在婴儿中的应用:一种新型 Amplatzer 封堵器的实验测试。
Catheter Cardiovasc Interv. 2014 Feb;83(2):250-5. doi: 10.1002/ccd.22931. Epub 2013 Oct 23.
7
Innovative resource utilization to fashion individualized covered stents in the setting of aortic coarctation.创新性资源利用在主动脉缩窄环境下定制覆膜支架。
Catheter Cardiovasc Interv. 2011 Sep 1;78(3):413-8. doi: 10.1002/ccd.22999.
8
Indications for cardiac catheterization and intervention in pediatric cardiac disease: a scientific statement from the American Heart Association.小儿心脏疾病的心导管检查及介入治疗指征:美国心脏协会的科学声明
Circulation. 2011 Jun 7;123(22):2607-52. doi: 10.1161/CIR.0b013e31821b1f10. Epub 2011 May 2.
9
The off-versus on-label use of medical devices in interventional cardiovascular medicine?: Clarifying the ambiguity between regulatory labeling and clinical decision making, part III: structural heart disease interventions.
Catheter Cardiovasc Interv. 2008 Nov 15;72(6):848-52. doi: 10.1002/ccd.21708.
10
Early restenosis following biodegradable stent implantation in an aortopulmonary collateral of a patient with pulmonary atresia and hypoplastic pulmonary arteries.一名患有肺动脉闭锁和肺动脉发育不全患者的主肺动脉侧支血管内植入可生物降解支架后早期再狭窄。
Catheter Cardiovasc Interv. 2007 Apr 1;69(5):735-8. doi: 10.1002/ccd.21091.